JANEX | PMAQX | JANEX / PMAQX | |
Total Expense Ratio | 0.79 | 0.59 | 134% |
Annual Report Gross Expense Ratio | 0.79 | 0.59 | 134% |
Fund Existence | 33 years | 9 years | - |
Gain YTD | 4.665 | 7.148 | 65% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.2B | 32.3B | 69% |
Annual Yield % from dividends | 1.00 | 0.19 | 532% |
Returns for 1 year | 7.86 | 15.77 | 50% |
Returns for 3 years | 17.97 | 53.80 | 33% |
Returns for 5 years | 13.02 | 62.17 | 21% |
Returns for 10 years | 64.68 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FLRG | 36.19 | 0.32 | +0.90% |
Fidelity U.S. Multifactor ETF | |||
XDSQ | 37.76 | 0.25 | +0.68% |
Innovator US Eq Acltd ETF™ Quarterly | |||
VIG | 207.81 | 1.35 | +0.65% |
Vanguard Dividend Appreciation ETF | |||
GSST | 50.41 | 0.03 | +0.06% |
Goldman Sachs Ultra Short Bond ETF | |||
LGHT | 10.48 | -0.01 | -0.13% |
Langar Global HealthTech ETF |